Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leticia M Toledo-Sherman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Drug Discovery & Development|June 13, 2002
High-throughput virtual screening for drug discovery in parallelLeticia M Toledo-Sherman, Deqi Chen
Journal of Biomolecular Screening|May 22, 2013
Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO)Dirk Winkler, Maria Beconi, Leticia M Toledo-Sherman, et al.
Molecular Diversity|February 18, 2004
Novel magnetic supports for small molecule affinity capture of proteins for use in proteomicsIrving Sucholeiki, Leticia M Toledo-Sherman, Christopher M Hosfield, et al.
Alzheimer'S Research & Therapy|October 6, 2023
The therapeutic landscape of tauopathies: challenges and prospectsJeffrey L Cummings, M Isabel Gonzalez, Martyn C Pritchard, et al.
Journal of Medicinal Chemistry|January 16, 2015
Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's diseaseLeticia M Toledo-Sherman, Michael E Prime, Ladislav Mrzljak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2021
Current directions in tau research: Highlights from Tau 2020Claire Sexton, Heather Snyder, Dirk Beher, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Drug Discovery & Development|June 13, 2002
High-throughput virtual screening for drug discovery in parallelLeticia M Toledo-Sherman, Deqi Chen
Journal of Biomolecular Screening|May 22, 2013
Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO)Dirk Winkler, Maria Beconi, Leticia M Toledo-Sherman, et al.
Molecular Diversity|February 18, 2004
Novel magnetic supports for small molecule affinity capture of proteins for use in proteomicsIrving Sucholeiki, Leticia M Toledo-Sherman, Christopher M Hosfield, et al.
Alzheimer'S Research & Therapy|October 6, 2023
The therapeutic landscape of tauopathies: challenges and prospectsJeffrey L Cummings, M Isabel Gonzalez, Martyn C Pritchard, et al.
Journal of Medicinal Chemistry|January 16, 2015
Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's diseaseLeticia M Toledo-Sherman, Michael E Prime, Ladislav Mrzljak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2021
Current directions in tau research: Highlights from Tau 2020Claire Sexton, Heather Snyder, Dirk Beher, et al.
Pageof 1